Kevin Puylaert insider trades

Open-market stock purchases and sales by Kevin Puylaert, Chief Sales Officer at SOPHiA GENETICS SA, from SEC Form 4 filings since Mar 19, 2026.

Recent trades

DateStockTradeValue
Jul 6, 2026SOPH SOPHiA GENETICS SASold$693
Jul 6, 2026SOPH SOPHiA GENETICS SASold$236
Jul 6, 2026SOPH SOPHiA GENETICS SASold$158
May 19, 2026SOPH SOPHiA GENETICS SASold$150
Apr 20, 2026SOPH SOPHiA GENETICS SASold$168
Apr 6, 2026SOPH SOPHiA GENETICS SASold$2.7K
Apr 6, 2026SOPH SOPHiA GENETICS SASold$224
Apr 6, 2026SOPH SOPHiA GENETICS SASold$145
Apr 2, 2026SOPH SOPHiA GENETICS SABought (not open market)—
Apr 2, 2026SOPH SOPHiA GENETICS SABought (not open market)—
Apr 2, 2026SOPH SOPHiA GENETICS SABought (not open market)—
Apr 2, 2026SOPH SOPHiA GENETICS SABought (not open market)—
Mar 31, 2026SOPH SOPHiA GENETICS SASold$14
Mar 19, 2026SOPH SOPHiA GENETICS SASold$157

Companies traded

  • SOPH SOPHiA GENETICS SA: 10 sales, last Jul 6, 2026

Get free alerts when Kevin Puylaert files a new trade →